Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1951 1
1963 1
1966 1
1967 1
1970 2
1971 1
1972 3
1973 1
1974 4
1975 13
1976 15
1977 15
1978 11
1979 12
1980 18
1981 16
1982 14
1983 30
1984 35
1985 42
1986 42
1987 38
1988 34
1989 60
1990 58
1991 55
1992 70
1993 72
1994 101
1995 115
1996 104
1997 122
1998 118
1999 155
2000 151
2001 136
2002 152
2003 145
2004 184
2005 197
2006 205
2007 270
2008 271
2009 297
2010 304
2011 296
2012 396
2013 457
2014 540
2015 483
2016 411
2017 394
2018 457
2019 430
2020 459
2021 407
2022 378
2023 422
2024 141

Text availability

Article attribute

Article type

Publication date

Search Results

8,137 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Resectable Digestive System Carcinoma"
Page 1
MRI of cholangiocarcinoma.
Jhaveri KS, Hosseini-Nik H. Jhaveri KS, et al. J Magn Reson Imaging. 2015 Nov;42(5):1165-79. doi: 10.1002/jmri.24810. Epub 2014 Dec 1. J Magn Reson Imaging. 2015. PMID: 25447417 Review.
Cholangiocarcinomas are the second most common primary hepatobiliary tumors after hepatocellular carcinomas. They can be categorized either based on their location (intrahepatic/perihilar/extrahepatic distal) or their growth characteristics (mass-forming/periductal-infiltr …
Cholangiocarcinomas are the second most common primary hepatobiliary tumors after hepatocellular carcinomas. They can be categorized …
Justifying vein resection with pancreatoduodenectomy.
Barreto SG, Windsor JA. Barreto SG, et al. Lancet Oncol. 2016 Mar;17(3):e118-e124. doi: 10.1016/S1470-2045(15)00463-5. Epub 2016 Mar 2. Lancet Oncol. 2016. PMID: 26972858 Review.
This surgery includes extended lymphadenectomy, multivisceral resections, and synchronous arterial and venous resections. The evidence that these surgeries improve long-term survival is poor, except perhaps for synchronous venous resection, which can be justi …
This surgery includes extended lymphadenectomy, multivisceral resections, and synchronous arterial and venous resections. The …
Distal biliary malignancy.
Veillette G, Castillo CF. Veillette G, et al. Surg Clin North Am. 2008 Dec;88(6):1429-47, xi. doi: 10.1016/j.suc.2008.07.003. Surg Clin North Am. 2008. PMID: 18992603 Review.
In addition, identification of risk factors, use of tumor markers, and advanced molecular testing may enhance diagnostic and prognostic capabilities. The treatment of choice for resectable disease is pancreaticoduodenectomy and the overall 5-year survival for resected …
In addition, identification of risk factors, use of tumor markers, and advanced molecular testing may enhance diagnostic and prognostic capa …
Current State and Future Directions of Radiation Therapy for Pancreas Adenocarcinoma.
Gottumukkala S, Salamekh S, Sanford NN. Gottumukkala S, et al. Surg Oncol Clin N Am. 2023 Jul;32(3):399-414. doi: 10.1016/j.soc.2023.02.001. Epub 2023 Apr 4. Surg Oncol Clin N Am. 2023. PMID: 37182984 Review.
Studies suggest select patients from across the pancreatic adenocarcinoma (PDAC) disease spectrum may benefit from adding radiation therapy (RT) to multi-modality care. In resectable PDAC, there is an evolving role for neoadjuvant RT with adjuvant RT reserved for patients …
Studies suggest select patients from across the pancreatic adenocarcinoma (PDAC) disease spectrum may benefit from adding radiation therapy …
Role of surgery in pancreatic cancer.
Buanes TA. Buanes TA. World J Gastroenterol. 2017 Jun 7;23(21):3765-3770. doi: 10.3748/wjg.v23.i21.3765. World J Gastroenterol. 2017. PMID: 28638216 Free PMC article.
The sequence of treatment interventions has therefore become an important concern, and numerous ongoing randomized controlled trials compare clinical outcome after upfront surgery and neoadjuvant treatment with subsequent resection. In previous years, borderline resecta …
The sequence of treatment interventions has therefore become an important concern, and numerous ongoing randomized controlled trials compare …
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma.
Mattiucci GC, Autorino R, D'Agostino GR, Deodato F, Macchia G, Perri V, Tringali A, Morganti AG, Mutignani M, Valentini V. Mattiucci GC, et al. Crit Rev Oncol Hematol. 2014 Apr;90(1):58-67. doi: 10.1016/j.critrevonc.2013.10.007. Epub 2013 Nov 2. Crit Rev Oncol Hematol. 2014. PMID: 24289902 Review.
BACKGROUND: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when radiotherapy could be effective for this group of patients. METHODS: A systematic review of recently published literature was completed. Recent studies us …
BACKGROUND: To explore the role of radiotherapy in the extrahepatic bile duct carcinoma, and to understand if and when radiotherapy c …
Primary and metastatic liver cancer.
Groen KA. Groen KA. Semin Oncol Nurs. 1999 Feb;15(1):48-57. doi: 10.1016/s0749-2081(99)80039-4. Semin Oncol Nurs. 1999. PMID: 10074657 Free article. Review.
DATA SOURCES: Research studies, review articles, and textbooks relating to liver cancer. CONCLUSIONS: Surgical resection offers the best available treatment modality, but only a small percentage of patients are eligible. However, combined treatment of radiation therapy and …
DATA SOURCES: Research studies, review articles, and textbooks relating to liver cancer. CONCLUSIONS: Surgical resection offers the b …
Endoscopic or Surgical Resection for Gastro-Esophageal Cancer.
Gockel I, Hoffmeister A. Gockel I, et al. Dtsch Arztebl Int. 2018 Aug 6;115(31-32):513-519. doi: 10.3238/arztebl.2018.0513. Dtsch Arztebl Int. 2018. PMID: 30149830 Free PMC article. Review.
The development of endoscopic submucosal dissection has led to a higher R0 resection rate, a lower risk of recurrence, and an increase in the number of endoscopic resections that are performed with curative intent. ...CONCLUSION: Borderline cases between endoscopic …
The development of endoscopic submucosal dissection has led to a higher R0 resection rate, a lower risk of recurrence, and an increas …
Early esophageal cancer: the significance of surgery, endoscopy, and chemoradiation.
Mönig S, Chevallay M, Niclauss N, Zilli T, Fang W, Bansal A, Hoeppner J. Mönig S, et al. Ann N Y Acad Sci. 2018 Dec;1434(1):115-123. doi: 10.1111/nyas.13955. Epub 2018 Aug 23. Ann N Y Acad Sci. 2018. PMID: 30138532 Review.
Early carcinomas of the esophagus are histologically classified as adenocarcinoma or squamous cell carcinoma and microscopically subdivided into mucosal and submucosal carcinomas depending on infiltration depth. ...In superficial submucosal infiltration witho …
Early carcinomas of the esophagus are histologically classified as adenocarcinoma or squamous cell carcinoma and microscopical …
Clinical characteristics and surgical outcomes of resectable acinar cell carcinoma of the pancreas-propensity score matching analysis with pancreatic ductal adenocarcinoma.
Chen H, Xu Z, Shen Z, Weng Y, Wang W, Ying X, Wang X, Deng X, Shen B. Chen H, et al. Eur J Surg Oncol. 2022 May;48(5):1062-1067. doi: 10.1016/j.ejso.2021.11.135. Epub 2021 Dec 2. Eur J Surg Oncol. 2022. PMID: 34887166
BACKGROUND: Surgical resection is recommended for patients with resectable acinar cell carcinoma (ACC). ...After the 1:3 PSM, ACC remained to be a better histological type for OS (p = 0.024), but had comparable RFS with PDAC (p = 0.164). CONCLUSION: Patients …
BACKGROUND: Surgical resection is recommended for patients with resectable acinar cell carcinoma (ACC). ...After the 1: …
8,137 results